ICCM — IceCure Medical Ltd
$1.01+1.00%
Last close: · regular session
Last 60 sessions
Opening the full analysis uses 1 of your 3 free tickers today.
Chart, dilution, float and news for ICCM in the TickerWise workspace.
Headquartered in Caesarea, Israel, and founded in 2006, IceCure Medical Ltd is a medical device enterprise dedicated to inventing, refining, and marketing innovative solutions for treating human tumors through cryoablation, a freezing process. Their primary offering, the ProSense system, provides a specialized cryoablation therapy specifically for breast tumors.
Company profile
- Sector: Healthcare
- Industry: Medical - Devices
- Country: IL
- Exchange: NASDAQ Capital Market
- Employees: 64
- Website: https://www.icecure-medical.com
Latest SEC filings for ICCM
Latest ICCM news
- IceCure Highlights Clinical Data and Strong Physician Engagement for ProSense® Breast Cancer Cryoablation at EUSOBI 2026 Read article
- IceCure Expands ProSense® ChoICE Study for Low-Risk Breast Cancer adding Legacy Health in Portland, OR as U.S. Clinical Site Read article
- Reviewing IceCure Medical (NASDAQ:ICCM) & Precision Optics (NASDAQ:POCI) Read article
Opening the full analysis uses 1 of your 3 free tickers today.
Educational tool only — not investment advice.